Fever-Tree’s (FEVR) Hold Rating Reaffirmed at Shore Capital
Fever-Tree (LON:FEVR)‘s stock had its “hold” rating restated by analysts at Shore Capital in a research note issued on Thursday.
A number of other research analysts also recently weighed in on the company. Jefferies Group started coverage on Fever-Tree in a research note on Friday, January 19th. They issued a “buy” rating and a GBX 3,000 ($40.69) price target for the company. Royal Bank of Canada upgraded Fever-Tree to an “outperform” rating and raised their price target for the company from GBX 2,350 ($31.88) to GBX 3,300 ($44.76) in a research note on Monday, March 19th. Berenberg Bank raised their price target on Fever-Tree from GBX 2,850 ($38.66) to GBX 3,350 ($45.44) and gave the company a “buy” rating in a research note on Monday, March 19th. Finally, Morgan Stanley restated an “overweight” rating and issued a GBX 3,100 ($42.05) price target on shares of Fever-Tree in a research note on Tuesday, March 13th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of GBX 2,863.33 ($38.84).
Fever-Tree opened at GBX 2,824 ($38.31) on Thursday, MarketBeat Ratings reports. Fever-Tree has a twelve month low of GBX 1,353.93 ($18.37) and a twelve month high of GBX 2,926 ($39.69).
Fever-Tree Company Profile
Fevertree Drinks plc, together with its subsidiaries, develops and supplies premium mixer drinks in the United Kingdom, the United States, Europe, and internationally. The company's products include Indian tonic water, naturally light tonic water, Mediterranean tonic water, elderflower tonic water, aromatic tonic water, Clementine tonic water, ginger beer, naturally light ginger beer, ginger ale, Madagascan cola, bitter lemon, lemonade, Sicilian lemonade, spring soda water, and premium cola.
Receive News & Ratings for Fever-Tree Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fever-Tree and related companies with MarketBeat.com's FREE daily email newsletter.